Navigation Links
Bypass Patients Fare Equally Well With or Without Heart-Lung Machine
Date:3/12/2013

By E.J. Mundell
HealthDay Reporter

MONDAY, March 11 (HealthDay News) -- Coronary artery bypass surgeries are one of the most common heart operations, and three new studies find it makes little difference whether they are done with or without the aid of a heart-lung machine.

Patients having so-called "off-pump" (no heart-lung machine) bypass procedures fared equally well as those who got the "on-pump" version, even if they were very sick or elderly, the trio of studies found. On the other hand, patients who had bypass with the aid of a heart-lung machine also had no evidence of a higher risk of lowered mental function afterwards, something that prior studies had suggested might be a concern.

The studies were presented Monday in San Francisco at the annual meeting of the American College of Cardiology (ACC).

Bypass surgery involves the transplant of a vessel sourced from elsewhere in the patient's body to "bypass" a clogged artery servicing the heart. The procedure can be done while the heart is temporarily stopped and the patient is placed on a heart-lung machine, or it can be done in an "off-pump" mode, in which the surgeon lifts the still-beating heart out of the chest cavity to perform the necessary grafts.

Initially, experts worried that off-pump bypass might be too risky, especially for more frail patients. But the three new studies suggest otherwise.

One comparison study, the largest yet performed, was led by Dr. Andre Lamy of the division of cardiac surgery at McMaster University in Hamilton, Ontario. The trial involved more than 4,750 patients from 79 centers across 19 countries, who were scheduled to undergo bypass.

After one year of follow-up, the team found no significant difference in rates of death, stroke, heart attack or new kidney failure for people who got the off-pump procedure (12.2 percent) and those who got the on-pump version (13.3 percent).

"I think surgeons aro
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Moveable Magnets Used to Forge Gastric Bypass in Pigs
2. Lab-Grown Blood Vessels May Improve Heart Bypass
3. Less Invasive Surgery Safe for Harvesting Bypass Veins: Study
4. Stroke Risk Higher After Bypass Than Angioplasty: Analysis
5. Cardiac bypass surgery superior to non-surgical procedure for adults with diabetes and heart disease
6. Bypass Beats Stents for Diabetic Heart Patients: Study
7. Bypass surgery improves survival for patients with diabetes and multi-vessel coronary artery disease
8. Gastric bypass surgery helps diabetes but doesnt cure it
9. Gastric Bypass Supplements Redesigns Their Leading Website
10. Similar outcomes in older patients with on- or off-pump bypass
11. Study shows on-pump bypass comparable to off-pump at year mark
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bypass Patients Fare Equally Well With or Without Heart-Lung Machine
(Date:8/28/2015)... ... 2015 , ... The Nashville Business Journal recently announced its ... Mr. Troy Mizell, Chairman of the Board at MyGenetx, is one of ... Awards will recognize Nashville military veterans who, through their professional and personal efforts, ...
(Date:8/28/2015)... Arizona (PRWEB) , ... August 28, 2015 , ... ... and increased patient loyalty at a low cost. Personalized with practice contact information ... and existing patients. Dental offices can also incorporate Calendars into seasonal mailings, thank ...
(Date:8/28/2015)... ... ... Mendon, IL, home of the Adams County Fairgrounds, was treated once again ... cause. In its second year, the “Music With A Mission” benefit concert was held ... of “Music With A Mission” is to raise money to help fund music education ...
(Date:8/28/2015)... ... 2015 , ... The Louis W. Sullivan Institute for ... transform quality and efficiency of healthcare delivery worldwide, announced the release of a ... being publicly shared to document progress and inform policy in a report issued ...
(Date:8/28/2015)... ... August 28, 2015 , ... United Benefit Advisors ... TJS Insurance Group as its newest Partner Firm. Founded in 1924 and headquartered ... them focused on their goals. Within the past 10 years, TJS Insurance Group ...
Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:WEDI's The Sullivan Institute for Healthcare Innovation Releases Gaps in Care Survey 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 2Health News:TJS Insurance Group Is Latest Partner Firm To Join United Benefit Advisors 3
... 21 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... in conjunction with the American College of,Rheumatology Meeting ... Members of Rigel,s senior management team will provide ... a novel, oral Syk kinase,inhibitor. R788 is currently ...
... the,availability of MarketStats for health care technology equities ... a perspective on the,aforementioned equities and the opportunity ... Investors can view MarketStats by visiting: ... social networking site for,investors., Today,s MarketStats for ...
... Aid, an application for iPhone and iPod Touch, is released today ... the steps of Cardiopulmonary Resuscitation or how to act when someone ... ... 2008 -- Phone Aid, an application for iPhone and iPod Touch, ...
... has expanded the reach of its custom commercial printing by ... Canada and Europe. , ... Ft. ... commercial printing customers with international shipping options via FedEx, UPS ...
... Unchanged, ST. LOUIS, Oct. 20 KV Pharmaceutical ... Hologic, Inc., the,holder of the New Drug Application (NDA) ... has extended the PDUFA date on,Gestiva(TM) for ninety days ... extension is in line with the FDA,s standard operating ...
... heart attacks , , MONDAY, Oct. 20 (HealthDay News) -- A ... reduce the risks of surgery. , The death rate for ... higher in the 30 days after an operation than for ... according to a report in the October issue of the ...
Cached Medicine News:Health News:Rigel to Webcast Investor Update on October 27, 2008 2Health News:SectorWatch.biz Issues MarketStats on NWCI, ERES, STJ, MDT, BSX, and CSCX 2Health News:Save Lives with Your Mobile Phone - Doctor Releases First Aid Application for iPhone 2Health News:My1Stop.com Takes Commercial Printing Global with International Shipping of Custom Printed Products 2Health News:KV Provides Update on Gestiva(TM) PDUFA Date 2Health News:KV Provides Update on Gestiva(TM) PDUFA Date 3Health News:KV Provides Update on Gestiva(TM) PDUFA Date 4Health News:Questions Continue About Using Beta Blockers Before Surgery 2Health News:Questions Continue About Using Beta Blockers Before Surgery 3
(Date:8/28/2015)... 2015 According to a new ... Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology ... & Geography - Global Forecast to 2020", published by ... around 17,689.0 Million USD by 2020 at a CAGR ... 2020. Browse 191 Tables and 38 ...
(Date:8/28/2015)... 28, 2015 Research ... addition of the "Investigation Report on China,s ... Originally discovered by Welfide (Mitsubishi Tanabe ... Ltd) as an inflammatory drug, pranoprofen was later ... Ltd under the trade name of pranopulin for ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... announced the addition of the "Investigation Report on ... Developed by Roche under the trade name ... in the world. In Feb.26, 2010, it was approved ... injections available in China all ...
Breaking Medicine Technology:Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Pranoprofen Market, 2010-2019 2Investigation Report on China's Bevacizumab Market 2015-2019 2
... from Serial Outpatient Infusion Study in Patients with,Chronic ... Cardiology 56th Annual Scientific Session --, MOUNTAIN VIEW, ... Scios Inc. announced today that an exploratory,920-patient, Phase ... on the primary endpoint, a composite of death ...
... March 25, 2007 /PRNewswire/ -- Once-daily,dosing with ... antagonist, was associated with improvements,in signs and ... hospitalized patients receiving conventional care, without an,adverse ... These,data are from the short- and long-term ...
Cached Medicine Technology:Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7
Resorbable fixation system 1.5/2.0....
... By combining intra-operative ... imagery, Medtronic Surgical Navigation ... revolutionary product called SonoNav ... system built on the ...
... the two steps are performed in sequence ... single use disposable cartridge and placed in ... touches a button, and the cycle begins. ... Then the integral syringe pump concentrates fibrinogen, ...
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical...
Medicine Products: